Opdivo + Yervoy Combination Therapy Improves Long-Term Survival in Lung Cancer Patients, Reveals WCLC 2023 Keytruda + Chemotherapy Demonstrates Long-Term Survival Benefit for Metastatic Lung Cancer, Reports WCLC 2023
The World Lung Cancer Society International Conference (WCLC 2023) is currently taking place in Singapore from the 9th to the 12th, focusing on the latest advancements in the treatment of non-small cell lung cancer. During the conference, the effectiveness of immune checkpoint inhibitors in the long-term treatment of this type of cancer was highlighted. Opdivo […]
